Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications

Osteosarcoma is a primary malignant tumor that tends to threaten children and adolescents, and the 5-year event-free survival rate has not improved significantly in the past three decades, bringing grief and economic burden to patients and society. To date, the genetic background and oncogenesis mechanisms of osteosarcoma remain unclear, impeding further research. The tumor immune microenvironment has become a recent research hot spot, providing novel but valuable insight into tumor heterogeneity and multifaceted mechanisms of tumor progression and metastasis. However, the immune microenvironment in osteosarcoma has been vigorously discussed, and the landscape of immune and non-immune component infiltration has been intensively investigated. Here, we summarize the current knowledge of the classification, features, and functions of the main infiltrating cells, complement system, and exosomes in the osteosarcoma immune microenvironment. In each section, we also highlight the complex crosstalk network among them and the corresponding potential therapeutic strategies and clinical applications to deepen our understanding of osteosarcoma and provide a reference for imminent effective therapies with reduced adverse effects.

• Publication year

  2022

• Venue

  Frontiers in Immunology

• Publication date

  2022-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fimmu.2022.907550PMID 35720360PMCID 9198725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes

  2021influential reference
• Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma

  2021cited by this paper
• Prognostic Implications of the Complement Protein C1Q and Its Correlation with Immune Infiltrates in Osteosarcoma

  2021cited by this paper
• Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration

  2021cited by this paper
• Extracellular Vesicles in Osteosarcoma: Antagonists or Therapeutic Agents?

  2021cited by this paper
• Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma

  2021cited by this paper
• Immune classification of osteosarcoma

  2021influential reference
• BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma

  2021cited by this paper
• The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implications

  2021cited by this paper
• Application of Immune Infiltration Signature and Machine Learning Model in the Differential Diagnosis and Prognosis of Bone-Related Malignancies

  2021cited by this paper
• Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma

  2021cited by this paper
• Complement C1q (C1qA, C1qB, and C1qC) May Be a Potential Prognostic Factor and an Index of Tumor Microenvironment Remodeling in Osteosarcoma

  2021cited by this paper
• B Cell Orchestration of Anti-tumor Immune Responses: A Matter of Cell Localization and Communication

  2021cited by this paper
• Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma

  2021cited by this paper
• Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients

  2021cited by this paper
• Beyond immunosuppressive effects: dual roles of myeloid-derived suppressor cells in bone-related diseases

  2021influential reference
• Identification of a Novel Prognostic Gene Signature From the Immune Cell Infiltration Landscape of Osteosarcoma

  2021cited by this paper
• Screening a novel signature and predicting the immune landscape of metastatic osteosarcoma in children via immune-related lncRNAs

  2021cited by this paper
• CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment

  2021cited by this paper
• A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma

  2021influential reference
• Overcoming PD-1 Inhibitor Resistance with a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma

  2021cited by this paper
• New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma

  2021cited by this paper
• Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice

  2021cited by this paper
• Data-Driven Mathematical Model of Osteosarcoma

  2021cited by this paper
• Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma

  2021cited by this paper
• Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103+ conventional dendritic cells

  2020cited by this paper
• Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients

  2020cited by this paper
• Information Transfer and Biological Significance of Neoplastic Exosomes in the Tumor Microenvironment of Osteosarcoma

  2020cited by this paper
• Tumor-Derived Exosomes Induced M2 Macrophage Polarization and Promoted the Metastasis of Osteosarcoma Cells Through Tim-3.

  2020cited by this paper
• Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation

  2020cited by this paper
• LAIR-1 overexpression inhibits epithelial–mesenchymal transition in osteosarcoma via GLUT1-related energy metabolism

  2020cited by this paper
• Genetically Modified T-Cell Therapy for Osteosarcoma: Into the Roaring 2020s.

  2020cited by this paper
• The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem

  2020cited by this paper
• Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions

  2020cited by this paper
• Conditioned Medium of the Osteosarcoma Cell Line U2OS Induces hBMSCs to Exhibit Characteristics of Carcinoma-Associated Fibroblasts via Activation of IL-6/STAT3 Signaling.

  2020cited by this paper
• Pretreatment inflammatory indexes as prognostic predictors for survival in osteosarcoma patients.

  2020cited by this paper
• Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma

  2020cited by this paper
• ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma

  2020cited by this paper
• Mifamurtide and TAM-like macrophages: effect on proliferation, migration and differentiation of osteosarcoma cells

  2020cited by this paper
• Activation of TLR4 signaling inhibits progression of osteosarcoma by stimulating CD8-positive cytotoxic lymphocytes

  2020cited by this paper
• Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma

  2020cited by this paper
• Cell adhesion in cancer: Beyond the migration of single cells

  2020cited by this paper
• Circulating tumor cells as an emerging tool in cancer therapy.

  2020cited by this paper
• Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate.

  2020cited by this paper
• Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma

  2020influential reference
• Blocking the Notch signal transduction pathway promotes tumor growth in osteosarcoma by affecting polarization of TAM to M2 phenotype

  2020cited by this paper
• Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.

  2019cited by this paper
• Epigenetic alterations in mesenchymal stem cells by osteosarcoma-derived extracellular vesicles

  2019cited by this paper
• Tumor-Associated Neutrophils in Cancer: Going Pro

  2019cited by this paper
• Mechanisms of natural killer cell‐mediated cellular cytotoxicity

  2019cited by this paper
• The Heterogeneity of Osteosarcoma: The Role Played by Cancer Stem Cells.

  2019cited by this paper
• Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile

  2019cited by this paper
• Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells

  2019cited by this paper
• Self-seeding circulating tumor cells promote the proliferation and metastasis of human osteosarcoma by upregulating interleukin-8

  2019cited by this paper
• Natural killer cells: a Review of biology, therapeutic potential and challenges in treatment of solid tumors.

  2019cited by this paper
• SDF-1/CXCR4 axis facilitates myeloid-derived suppressor cells accumulation in osteosarcoma microenvironment and blunts the response to anti-PD-1 therapy.

  2019cited by this paper
• Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells

  2019cited by this paper
• Impairment of NKG2D-Mediated Tumor Immunity by TGF-β

  2019cited by this paper
• Dendritic Cells Drive Osteosarcomagenesis through Newly Identified Oncogene and Tumor Suppressor.

  2019cited by this paper
• TIM3 comes of age as an inhibitory receptor

  2019cited by this paper
• PD‑L1/PD‑1 axis serves an important role in natural killer cell‑induced cytotoxicity in osteosarcoma.

  2019cited by this paper
• Activation of hedgehog signaling in mesenchymal stem cells induces cartilage and bone tumor formation via Wnt/β-Catenin

  2019cited by this paper
• Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23.

  2019cited by this paper
• Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2018cited by this paper
• Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications

  2018cited by this paper
• Pretreatment Inflammatory Indexes as Prognostic Predictors for Survival in Colorectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy

  2018cited by this paper
• Bone marrow‐derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition

  2018cited by this paper
• Activation of the complement system in an osteosarcoma cell line promotes angiogenesis through enhanced production of growth factors

  2018cited by this paper
• Interaction between human osteosarcoma and mesenchymal stem cells via an interleukin-8 signaling loop in the tumor microenvironment

  2018cited by this paper
• Current and future therapeutic approaches for osteosarcoma

  2018cited by this paper
• Exosomes originating from MSCs stimulated with TGF‐β and IFN‐γ promote Treg differentiation

  2018cited by this paper
• Human dendritic cell subsets: an update

  2018cited by this paper
• Tumor Syndromes Predisposing to Osteosarcoma.

  2018cited by this paper
• Blockade of Myeloid-Derived Suppressor Cell Expansion with All-Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy.

  2018cited by this paper
• A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells.

  2018cited by this paper
• Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2018cited by this paper
• CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis

  2018cited by this paper
• Clinicopathological and immunohistochemical analysis of autoimmune regulator expression in patients with osteosarcoma

  2018cited by this paper
• Interaction between mesenchymal stromal cell‐derived extracellular vesicles and immune cells by distinct protein content

  2018cited by this paper
• Novel Antibody Drug Conjugates Targeting Tumor-Associated Receptor Tyrosine Kinase ROR2 by Functional Screening of Fully Human Antibody Libraries Using Transpo-mAb Display on Progenitor B Cells

  2018cited by this paper
• Paget's disease of bone.

  2018cited by this paper
• Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend

  2018cited by this paper
• Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects

  2018cited by this paper
• Mesenchymal Stromal Cell-Derived Exosomes Affect mRNA Expression and Function of B-Lymphocytes

  2018cited by this paper
• Specific inhibition of PI3Kδ/γ enhances the efficacy of anti-PD1 against osteosarcoma cancer

  2018cited by this paper
• Exosomes from Osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cells

  2017cited by this paper
• Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression

  2017cited by this paper
• Combination therapy with L-arginine and α-PD-L1 antibody boosts immune response against osteosarcoma in immunocompetent mice

  2017cited by this paper
• Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells

  2017cited by this paper
• All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages

  2017cited by this paper
• Myeloid-Derived Suppressor Cells

  2017cited by this paper
• Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors

  2017cited by this paper
• B cell regulation in cancer and anti-tumor immunity

  2017cited by this paper
• Screening of candidate key genes associated with human osteosarcoma using bioinformatics analysis

  2017cited by this paper
• Pretreatment Neutrophil-to-Lymphocyte Ratio and Lymphocyte Recovery: Independent Prognostic Factors for Survival in Pediatric Sarcomas

  2017cited by this paper
• Inhibition of IL-18-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy against osteosarcoma cancer

  2017cited by this paper
• Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G

  2017cited by this paper
• The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma.

  2017cited by this paper
• Neutrophil extracellular traps in immunity and disease

  2017cited by this paper
• Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma

  2017cited by this paper

• Immune Infiltration Landscape in Osteosarcoma: Clinical Implications for Prognosis and Therapy

  2026cites this paper
• Characterizing two subtypes of osteosarcoma using G2M checkpoint-related genes and revealing its immune landscape.

  2026cites this paper
• Extracellular Vesicles in Osteosarcoma: Mechanisms, Diagnostics and Therapeutic Applications

  2026cites this paper
• Dual-Responsive Micelles Co-delivering All-Trans Retinoic Acid and Paclitaxel for Enhanced Eradication of Osteosarcoma Stem Cells

  2026cites this paper
• Iron-Related Metabolic Targets in the Treatment of Osteosarcoma: Research Progress and Prospects

  2025cites this paper
• Single-cell RNA sequencing in osteosarcoma: applications in diagnosis, prognosis, and treatment

  2025cites this paper
• Overcoming barriers in primary bone cancer: Nanomaterial-enabled immunotherapy

  2025cites this paper
• Advancements in research regarding the influence of the tumor microenvironment on the proliferation and metastasis of osteosarcoma (Review)

  2025influential citation
• Decoding the immune microenvironment in osteosarcoma: new insights into checkpoints, vaccines, and CAR-T cells

  2025cites this paper
• Pathology-interpretable radiomic model for predicting clinical outcome in patients with osteosarcoma: a retrospective, multicenter study

  2025cites this paper
• The immune microenvironment in chordoma: Implications for future treatment.

  2025cites this paper
• Prognostic model of osteosarcoma based on telomere-related genes and analysis of immune characteristics.

  2025cites this paper
• Nanotechnology-Driven Strategies in Osteosarcoma Advances in Treatment: Immunotherapy and Drug Delivery

  2025cites this paper
• Exploring the Tumor Microenvironment in Osteosarcoma: Driver of Resistance and Progression

  2025cites this paper
• Immune-Modulating Dual-Targeted Nanomaterials for Low-Temperature Photothermal–Photodynamic–Chemodynamic Therapy of Osteosarcoma Targeting Tumor and Endothelial Cells

  2025cites this paper
• Three-dimensional preclinical models for Osteosarcoma: Advances and translational prospects.

  2025cites this paper
• Targeting myeloid-derived suppressor cells in the tumor microenvironment: potential therapeutic approaches for osteosarcoma

  2025cites this paper
• Molecular and Glycosylation Pathways in Osteosarcoma: Tumor Microenvironment and Emerging Strategies Toward Personalized Oncology

  2025cites this paper
• Hino-Fe Chelate Suppresses Osteosarcoma Progression through Dual Induction of Ferroptosis and NLRC4-mediated Pyroptosis: Mechanisms and Therapeutic Implications

  2025cites this paper
• LncRNA-TIL1H mediates targeted regulation of the drug-resistant gene MDR1 and RAD21 to promote immune resistance and accelerate osteosarcoma progression.

  2025cites this paper
• Comprehensive multi-omics analysis of histone acetylation modulators identifies ASH1L as a novel aggressive marker for osteosarcoma

  2025cites this paper
• Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights

  2025influential citation
• Immunosuppressive Tumor Microenvironment of Osteosarcoma

  2025cites this paper
• Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity

  2025cites this paper
• Prioritizing Context-Dependent Cancer Gene Signatures in Networks

  2025cites this paper
• Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeutics

  2025cites this paper
• Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives

  2025cites this paper
• TFRC promotes the proliferation, migration, and invasion of osteosarcoma cells by increasing the intracellular iron content and RRM2 expression

  2025cites this paper
• Exploratory Analysis of Molecular Subtypes in Early-Stage Osteosarcoma: Identifying Resistance and Optimizing Therapy

  2025cites this paper
• Knowledge of Malignant Bone Tumors in Children Among Parents in Majmaah Region

  2025cites this paper
• Evaluation of Indoleamine 2,3-Dioxygenase (IDO) Expression in Osteosarcoma: Insights From a 10-Year Retrospective Cohort

  2025cites this paper
• Integrated analysis of multiple programmed cell death-related prognostic genes and functional validation of apoptosis-related genes in osteosarcoma.

  2025cites this paper
• Interfering with UBE2L3 expression targets regulation of MLKL to promote necroptosis inhibition of growth in osteosarcoma

  2025cites this paper
• Heterogenic membrane-coated nanoparticles for targeted immunotherapy against osteosarcoma via p53-mediated ferroptosis and mTOR inhibition

  2025cites this paper
• Osteosarcoma-on-a-chip model mimicking intra-tumoral heterogeneity to interrogate tumor-associated macrophage reprogramming for immunotherapeutics.

  2025cites this paper
• A Spatiotemporal Model of CXCL10 as a Master Regulator of Immune Evasion and Metastasis in Osteosarcoma

  2025cites this paper
• Dynamic assessment of a humanized bone tumour microenvironment reveals insights into osteosarcoma primary tumour remodelling and lung metastases

  2025cites this paper
• Role of tumor-derived exosomes and immune cells in osteosarcoma progression and targeted therapy

  2025cites this paper
• Amino acid transporter SLC7A11 functions in ferroptosis regulation and immune microenvironment in osteosarcoma.

  2025cites this paper
• Spatial multiplexed immunofluorescence analysis reveals coordinated cellular networks associated with overall survival in metastatic osteosarcoma

  2024cites this paper
• A CIC-related-epigenetic factors-based model associated with prediction, the tumor microenvironment and drug sensitivity in osteosarcoma

  2024cites this paper
• Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress

  2024cites this paper
• Zoledronic acid enhances tumor growth and metastatic spread in a mouse model of jaw osteosarcoma.

  2024cites this paper
• Intelligent structure prediction and visualization analysis of non-coding RNA in osteosarcoma research

  2024cites this paper
• RETRACTED: Deciphering the prognostic landscape of osteosarcoma: Integrating the roles of hippo pathway genes, programmed cell death, and the tumor immune microenvironment

  2024cites this paper
• Enhanced pyroptosis induction with pore-forming gene delivery for osteosarcoma microenvironment reshaping

  2024cites this paper
• PRG4 represses the genesis and metastasis of osteosarcoma by inhibiting PDL1 expression.

  2024cites this paper
• Potential predictive value of immune-related genes FUCA1 and NCKAP1L for osteosarcoma metastasis.

  2024cites this paper
• Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies

  2024cites this paper
• MATN4 as a target gene of HIF-1α promotes the proliferation and metastasis of osteosarcoma

  2024cites this paper
• Exploring the Role of Neutrophil-Related Genes in Osteosarcoma via an Integrative Analysis of Single-Cell and Bulk Transcriptome

  2024cites this paper
• Pediatric cancer—pathology and microenvironment influence: a perspective into osteosarcoma and non-osteogenic mesenchymal malignant neoplasms

  2024cites this paper
• Targeted anti-angiogenesis therapy for advanced osteosarcoma

  2024cites this paper
• Synergistic effect of waste-derived β-tricalcium phosphate microbeads loaded in hydroxyapatite-keratin-polyvinyl alcohol composite matrix in drug release for osteosarcoma treatment

  2024cites this paper
• Network pharmacology, molecular docking, and molecular dynamics simulations shed light on the mechanism behind Gynostemma pentaphyllum’s efficacy against osteosarcoma

  2024cites this paper
• Nonviral genetic manipulation system with microenvironmental cascade sensitivity for the treatment of TNBC-associated metastatic bone tumor

  2024cites this paper
• Make it STING: nanotechnological approaches for activating cGAS/STING as an immunomodulatory node in osteosarcoma

  2024influential citation
• From Spheroids to Bioprinting: A Literature Review on Biomanufacturing Strategies of 3D In Vitro Osteosarcoma Models

  2024cites this paper
• Current insights and future directions of Li-Fraumeni syndrome

  2024cites this paper
• Advancing osteosarcoma 3D modeling in vitro for novel tumor microenvironment-targeted therapies development.

  2024cites this paper
• The role of neutrophils in osteosarcoma: insights from laboratory to clinic

  2024cites this paper
• CD47 in Osteosarcoma: Correlation with Metastasis and Macrophage-Mediated Phagocytosis

  2024cites this paper
• m6A methylation modification: Potential pathways to suppress osteosarcoma metastasis.

  2024cites this paper
• Exploration of metastasis-related signatures in osteosarcoma based on tumor microenvironment by integrated bioinformatic analysis

  2024cites this paper
• Using β-Elemene to reduce stemness and drug resistance in osteosarcoma: A focus on the AKT/FOXO1 signaling pathway and immune modulation

  2024cites this paper
• Whole-Exome Analysis and Osteosarcoma: A Game Still Open

  2024cites this paper
• Immunosuppressive tumor microenvironment of osteosarcoma

  2024cites this paper
• Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and in vitro experiments

  2023cites this paper
• Development and validation of neutrophil extracellular traps-derived signature to predict the prognosis for osteosarcoma patients.

  2023cites this paper
• Single-cell RNA sequencing reveals the immune microenvironment landscape of osteosarcoma before and after chemotherapy

  2023cites this paper
• The interaction between osteosarcoma and other cells in the bone microenvironment: From mechanism to clinical applications

  2023cites this paper
• Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities

  2023cites this paper
• Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application

  2023cites this paper
• The Roles of Exosomes in Metastasis of Sarcoma: From Biomarkers to Therapeutic Targets

  2023cites this paper
• Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment

  2023cites this paper
• Deciphering the Molecular Mechanism of Yifei-Sanjie Pill in Cancer-Related Fatigue

  2023cites this paper
• Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma

  2023influential citation
• Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma—A Narrative Review

  2023cites this paper
• Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma

  2023cites this paper
• Unveiling the prognostic implications of RPLP1 upregulation in osteosarcoma.

  2023cites this paper
• Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis

  2023cites this paper
• Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma

  2023cites this paper
• Construction of 5-fluorouracil Loaded Polydopamine Tailored Zeolite Imidazole Framework (ZIF-8) as Potential Treatment for Osteosarcoma Cancer

  2023cites this paper
• Relationship between tumorigenesis, metastasis, immune evasion, and chemoresistance in osteosarcoma therapy

  2023cites this paper
• Promise and Challenges of T Cell Immunotherapy for Osteosarcoma

  2023cites this paper
• Tumor microenvironment phenotypes and prognostic evaluation tools for osteosarcoma characterized by different prognostic outcomes and immunotherapy responses

  2023cites this paper
• Necroptosis in the sarcoma immune microenvironment: From biology to therapy.

  2023cites this paper
• Metabolism and senescence in the immune microenvironment of osteosarcoma: focus on new therapeutic strategies

  2023cites this paper
• A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma.

  2023cites this paper
• Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1–3, suppresses osteosarcoma proliferation and invasion via dual role in tumor cells and tumor microenvironment

  2023cites this paper
• The heterogeneity and drug resistance of malignant cells and intercellular communication of microenvironment in osteosarcoma: Based on single‐cell analysis

  2023cites this paper
• Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis

  2023cites this paper
• Different Subtypes of Osteosarcoma: Histopathological Patterns and Clinical Behaviour

  2023cites this paper
• The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma

  2022cites this paper
• Development of personalized classifier based on metastasis and the immune microenvironment to predict the prognosis of osteosarcoma patients

  2022cites this paper
• Characterization of osteosarcoma subtypes mediated by macrophage-related genes and creation and validation of a risk score system to quantitatively assess the prognosis of osteosarcoma and reflect the tumor microenvironment

  2022cites this paper
• Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma

  2022cites this paper
• A 3D Collagen-Based Bioprinted Model to Study Osteosarcoma Invasiveness and Drug Response

  2022cites this paper
• Recent Advances in DNA Vaccines against Lung Cancer: A Mini Review

  2022cites this paper
• Identi�cation of Differentially Expressed Genes in two Types of Osteosarcoma cell lines upon Zinc Oxide Nanoparticles Treatment Using the RNA-seq Technique

  year unknowncites this paper